Compounds, compositions and methods thereof
AssigneeHepaitech (Beijing) Biopharma Technology Co., Ltd.
InventorsRuichao Richard Shen, Xiaoguang Lei, Xiaoming Wang, Yulong Li
Life of this patent
Estimating the term…
Abstract
Among other things, the present disclosure provides compounds, e.g., of formula I or salts thereof. In some embodiments, the present disclosure provides methods for modulating MRGPRX4 activity. In some embodiments, the present disclosure provides methods for preventing or treating conditions, disorders or diseases, e.g., MRGPRX4-associated conditions, disorders or diseases.
Claims10
A compound has the structure of formula I:
- or a salt thereof, wherein:
- R1 is an isostere of —C(O)OH, or —C(O)OR11, —C(O)N(R12)SO2R13, —C(O)NR14R15, or
- —X1═X2— is —X1═X2— and X1 and X2 is independently —N═, —CR2═, or optionally substituted —CH═;
- or —X1 ═X2— is optionally substituted (CH2)2—;
- R2 is optionally substituted C1-6 alkyl;
- X3 is —N═, or —CR3═;
- X4 is —N═, or —CR4═;
- each of R3, R4 and R5 is independently R′, OR′, halogen, —CN, —NO2, or —N(R′)2;
- each of R11, R12, R13, R14 and R15 is independently R′;
- L is optionally substituted —(CH2)m—;
- m is 1 or 2;
- Ring A is an optionally substituted ring selected from a 6-10 membered aryl ring and a 5-10 membered heteroaryl ring having 1-6 heteroatoms, or Ring A is
- wherein each Ra is independently —R′, —OR′, halogen, —CN, —NO2, or —N(R′)2 and n is 1-5;
- each R′ is independently R, —OR, —C(O)R, —C(O)OR, or —S(O)2R;
- each R is independently hydrogen or an optionally substituted group selected from C1-C6 aliphatic, C1-C6 heteroaliphatic having 1-3 heteroatoms, 3-10 membered cycloaliphatic, 3-10 membered heterocyclyl having 1-4 heteroatoms, 6-10 membered aryl, 5-10 membered heteroaryl having 1-6 heteroatoms, 6-10 membered aryl-C1-C6 aliphatic, and 5-10 membered heteroaryl having 1-6 heteroatoms-C1-C6 aliphatic;
- or
- two R groups on the same atom are optionally and independently taken together with the atom to form an optionally substituted 3-10 membered ring having, in addition to the atom, 0-4 heteroatoms;
- or
- two R groups on two atoms are optionally and independently taken together with their intervening atoms to form an optionally substituted 3-10 membered ring having, in addition to the intervening atoms, 0-4 heteroatoms.
A compound, wherein the compound has a structure selected from
- or a salt thereof.
A pharmaceutical composition comprising a compound of any one of the preceding claims and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.